We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx and Spirogen Enter Into a Research Collaboration

News   Sep 16, 2013

 
Ablynx and Spirogen Enter Into a Research Collaboration
 
 
 

RELATED ARTICLES

Scientists Crack the Chemical Code of Complex “Anti-tumor Antibiotic”

News

After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex "anti-tumor antibiotic" known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.

READ MORE

Targeted Therapy Proves Effective Against Aggressive Blood Cancer in Clinical Trial

News

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN).

READ MORE

Exposing and Exploiting Cancer’s Metabolic Addictions

News

Where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE